Tetherex Pharmaceuticals Corporation, located in Oklahoma City, is a privately held clinical-stage development biopharmaceutical company focused on development of therapeutics for the treatment of inflammation and tumors across a broad range of severe diseases as well as single-cycle adenovirus vaccines for multiple infectious diseases.